ID   Marcus
AC   CVCL_3019
SY   AJ
DR   BioSample; SAMN03472776
DR   Cell_Model_Passport; SIDM00378
DR   CGH-DB; 149-1
DR   IARC_TP53; 21524
DR   JCRB; IFO50290
DR   Wikidata; Q54904028
RX   PubMed=283420;
RX   PubMed=16232199;
CC   Population: Caucasian.
CC   Discontinued: JCRB; IFO50290; probable.
ST   Source(s): JCRB=IFO50290
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=283420; DOI=10.1073/pnas.75.10.5122;
RA   Pfreundschuh M., Shiku H., Takahashi T., Ueda R., Ransohoff J.F.,
RA   Oettgen H.F., Old L.J.;
RT   "Serological analysis of cell surface antigens of malignant human
RT   brain tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 75:5122-5126(1978).
//
RX   PubMed=16232199; DOI=10.1111/j.1349-7006.2005.00099.x;
RA   Saigusa K., Hashimoto N., Tsuda H., Yokoi S., Maruno M., Yoshimine T.,
RA   Aoyagi M., Ohno K., Imoto I., Inazawa J.;
RT   "Overexpressed Skp2 within 5p amplification detected by array-based
RT   comparative genomic hybridization is associated with poor prognosis of
RT   glioblastomas.";
RL   Cancer Sci. 96:676-683(2005).
//